Viewing Study NCT06611007



Ignite Creation Date: 2024-10-26 @ 3:41 PM
Last Modification Date: 2024-10-26 @ 3:41 PM
Study NCT ID: NCT06611007
Status: NOT_YET_RECRUITING
Last Update Posted: None
First Post: 2024-09-20

Brief Title: Evaluation of the Safety of Lipiodol Embolization in Symptomatic Digital Osteoarthritis Refractory to Conventional Treatment a Pilot Study of 15 Patients
Sponsor: None
Organization: None

Study Overview

Official Title: Evaluation of the Safety of Lipiodol Embolization in Symptomatic Digital Osteoarthritis Refractory to Conventional Treatment a Pilot Study of 15 Patients
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: EMBARDI
Brief Summary: The goal of this clinical trial is to evaluate the safety of arterial embolization using Lipiodol in patients with symptomatic hand osteoarthritis refractory to conventional treatment It will also learn about the efficacy of arterial embolization with Lipiodol in reducing pain and improving hand function

The main questions it aims to answer are

What are the side effects and complications associated with the Lipiodol arterial embolization procedure
Does arterial embolization reduce pain intensity and improve hand function

Researchers will evaluate patients over a 6-month period to assess the safety of Lipiodol embolization and its impact on joint pain swelling and functional capacity Participants will

Undergo arterial embolization with Lipiodol
Participate in regular follow-ups to monitor pain relief hand function and any side effects
Have imaging studies to assess changes in joint vascularisation and damage
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None